Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Operating Expenses: 2020-2022

Historic Operating Expenses for Atea Pharmaceuticals (AVIR) over the last 3 years, with Dec 2022 value amounting to $39.9 million.

  • Atea Pharmaceuticals' Operating Expenses fell 43.80% to $39.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $130.7 million, marking a year-over-year decrease of 38.66%. This contributed to the annual value of $192.9 million for FY2024, which is 17.54% up from last year.
  • Latest data reveals that Atea Pharmaceuticals reported Operating Expenses of $39.9 million as of Q4 2022, which was up 145.06% from $16.3 million recorded in Q3 2022.
  • In the past 5 years, Atea Pharmaceuticals' Operating Expenses ranged from a high of $71.0 million in Q4 2021 and a low of $4.0 million during Q2 2020.
  • Over the past 3 years, Atea Pharmaceuticals' median Operating Expenses value was $35.3 million (recorded in 2021), while the average stood at $35.8 million.
  • In the last 5 years, Atea Pharmaceuticals' Operating Expenses skyrocketed by 1,178.22% in 2021 and then plummeted by 70.38% in 2022.
  • Atea Pharmaceuticals' Operating Expenses (Quarterly) stood at $28.0 million in 2020, then spiked by 153.69% to $71.0 million in 2021, then crashed by 43.80% to $39.9 million in 2022.
  • Its last three reported values are $39.9 million in Q4 2022, $16.3 million for Q3 2022, and $32.3 million during Q2 2022.